All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @hez.gets.healthy on TikTok · 78s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @hez.gets.healthy's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00If you are currently stalling in your weight loss or going through a bit of a plateau,
  2. 0:06this is a public service announcement for you.
  3. 0:09It welcomed to an end.
  4. 0:11I know that from experience because I have stalled for the last like eight weeks or
  5. 0:16something like that may be longer.
  6. 0:18I've been yo-yoing back and forward in the same half a pound, which has been extremely
  7. 0:23frustrating.
  8. 0:24But last week I lost a pound and a half.
  9. 0:28And this week I've actually lost three pounds.
  10. 0:32So that has taken me to whirl over the 6th stone loss mark, which is what I was hovering
  11. 0:38about for ages.
  12. 0:40And I'm also two and a half pounds away from the 17s from dropping down in a new stone
  13. 0:47bracket.
  14. 0:48Chick your calories.
  15. 0:51So double-chick your TD.
  16. 0:54Make sure that your calories are still accurate, especially if you've already lost a lot of
  17. 0:58weight.
  18. 0:59That was one of the issues that I had was I was eating about 400 more calories a day than
  19. 1:05what I actually should be for my updated body weight now that I've lost 6th stone.
  20. 1:11But yeah, it'll come 10-1.
  21. 1:13Just keep going.
  22. 1:14Don't give up.
  23. 1:16It'll happen.

GLP-1 weight loss plateaus: what the science says about breaking through

✨️Heather✨️ First Time Mum 🤍

TikTok creator

2.0K viewsWatch on TikTok

Quick answer

After approximately 38 kilograms of weight loss on tirzepatide, this creator's experience of stalling and then recalibrating her calorie intake reflects a well-documented physiological reality: TDEE decreases substantially with significant weight reduction, and patients who do not update their intake targets will inadvertently eat at or above maintenance. Clinically, TDEE recalculation is a standard recommendation in weight management, but prescribers should also assess adaptive thermogenesis, GLP-1 dose appropriateness, and whether the plateau represents a new physiological equilibrium rather than a tracking error alone.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded TirzepatideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Tirzepatide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 weight loss plateaus: what the science says about breaking through, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Tirzepatide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this tirzepatide video claims cluster

Best for searchers deciding whether tirzepatide claims are stronger, safer, or more relevant than semaglutide claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GLP-1 weight loss plateaus: what the science says about breaking through" from ✨️Heather✨️ First Time Mum 🤍. We read the clip as a GLP-1 social video fact-checks claim about Compounded Tirzepatide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: After approximately 38 kilograms of weight loss on tirzepatide, this creator's experience of stalling and then recalibrating her calorie intake reflects a well-documented physiological reality: TDEE decreases substantially with significant weight reduction, and patients who do not update their intake targets will inadvertently eat at or above maintenance.

The reason this review is not generic is the source wording and the canonical claim label "glp1 the plateau will end weightlossjourney plateau glp1forweight." In this clip, the useful excerpt is: "If you are currently stalling in your weight loss or going through a bit of a plateau, this is a public service announcement for you." That wording changes the review because it points to Compounded Tirzepatide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Tirzepatide Once Weekly for the Treatment of Obesity (2022), Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (2024), and Tirzepatide for Obesity Treatment and Diabetes Prevention (2025), plus the creator's own wording. Compounded Tirzepatide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Adaptive thermogenesis means your actual metabolic rate can sit below what TDEE calculators predict after major weight loss, documented in Rosenbaum and Leibel (2010, NEJM).
People who land here are usually comparing the Compounded Tirzepatide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Tirzepatide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

After approximately 38 kilograms of weight loss on tirzepatide, this creator's experience of stalling and then recalibrating her calorie intake reflects a well-documented physiological reality: TDEE decreases substantially with significant weight reduction, and patients who do not update their intake targets will inadvertently eat at or above maintenance.

FormBlends verdict

Compounded Tirzepatide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Tirzepatide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • After approximately 38 kilograms of weight loss on tirzepatide, this creator's experience of stalling and then recalibrating her calorie intake reflects a well-documented physiological reality: TDEE decreases substantially with significant weight reduction, and patients who do not update their intake targets will inadvertently eat at or above maintenance. Clinically, TDEE recalculation is a standard recommendation in weight management, but prescribers should also assess adaptive thermogenesis, GLP-1 dose appropriateness, and whether the plateau represents a new physiological equilibrium rather than a tracking error alone.
  • TDEE decreases by roughly 300 to 500 calories after a 38 kg weight loss, making stale calorie targets a genuine and common plateau driver supported by Hall et al. (2022, Obesity).
  • Adaptive thermogenesis means your actual metabolic rate can sit below what TDEE calculators predict after major weight loss, documented in Rosenbaum and Leibel (2010, NEJM).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Tirzepatide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Tirzepatide guide, cost path, safety notes, and provider review before acting.

Review Compounded Tirzepatide

What You'll Learn

  • TDEE decreases by roughly 300 to 500 calories after a 38 kg weight loss, making stale calorie targets a genuine and common plateau driver supported by Hall et al. (2022, Obesity).
  • Adaptive thermogenesis means your actual metabolic rate can sit below what TDEE calculators predict after major weight loss, documented in Rosenbaum and Leibel (2010, NEJM).
  • SURMOUNT-1 trial data (Jastreboff et al., 2022, NEJM) shows tirzepatide-associated weight loss is not linear, and plateau periods are expected within the normal treatment course.
  • Recalculating TDEE using current bodyweight via the Mifflin-St Jeor equation is a reasonable first step when plateaued, but it is an estimate, not a personalised metabolic measurement.
  • Dose adjustments for GLP-1 medications should never be self-directed based on a plateau. This is a clinical decision requiring prescriber input.
  • A plateau lasting more than six to eight weeks on a GLP-1 medication warrants a conversation with your prescriber, not just a calorie audit.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @hez.gets.healthy actually say?

The short version: she stalled for roughly eight weeks on Mounjaro, broke through it last week with a pound and a half loss, then dropped three pounds this week. Her practical tip was blunt and specific: "double-check your TDEE" because she was eating "about 400 more calories a day" than her updated bodyweight required after losing six stone. She wrapped it with encouragement to keep going.

This is personal testimony, not a protocol. She is not claiming a medical intervention worked. She is sharing that rechecking her calorie target after significant weight loss appeared to break a plateau. That distinction matters when evaluating what she is actually putting out there.

Does the science back this up?

Yes, and more strongly than most TikTok plateau advice. The core claim, that your calorie needs drop as you lose weight, is one of the most replicated findings in obesity research and the mechanism is well understood.

When body weight falls, total daily energy expenditure (TDEE) falls with it. This happens through two routes. First, a lighter body simply burns fewer calories at rest. Second, there is a phenomenon called adaptive thermogenesis, where the body actively downregulates metabolism beyond what body composition alone would predict. Rosenbaum and Leibel (2010, New England Journal of Medicine) documented this clearly in long-term weight-reduced subjects. More recently, Hall et al. (2022, Obesity) confirmed that people maintaining large weight losses show suppressed energy expenditure relative to never-obese controls at the same weight.

The specific number she cited, around 400 calories, is plausible. A six-stone loss is approximately 38 kilograms. Standard TDEE calculators would reduce estimated maintenance by roughly 300 to 500 calories at that scale of loss, depending on activity level and starting weight. Her figure is not precise medical advice, but it is in the right ballpark.

What did they get wrong (or right)?

She got the core mechanism right. Eating to a stale calorie target after losing six stone is a genuine and common reason plateaus persist, and recalibrating TDEE is a legitimate first-line response. Credit where it is due.

What she did not mention is adaptive thermogenesis, the second driver, which matters. Even after correctly recalculating TDEE using a standard formula, some people will still plateau because their actual metabolic rate sits below what the formula predicts. TDEE calculators use population averages. They do not measure your personal metabolic adaptation. This means recalculating calories is a necessary step, not always a sufficient one.

She also implicitly frames the plateau as entirely within her control through calorie tracking. For GLP-1 users specifically, dose titration, injection timing, and individual receptor response variation all interact with weight trajectory in ways that a calorie check alone does not address. None of this makes her advice wrong. It makes it incomplete.

The encouragement framing, "it'll come, just keep going," is fine for motivation but could give some viewers false reassurance that persistence alone will break any plateau. Sometimes it will not, and a conversation with a prescriber is warranted.

What should you actually know?

If you are on a GLP-1 medication and have stalled, here is what the evidence actually supports as reasonable next steps.

  • Recalculate your TDEE using your current bodyweight, not your starting weight. Free tools like the Mifflin-St Jeor equation are reasonably accurate for most people. Her advice here is sound.
  • Understand that the formula gives an estimate. If you recalculate and still stall after four to six weeks, your individual metabolic adaptation may be running below the population average.
  • Plateaus on GLP-1 medications are documented in the trial data. In the SURMOUNT-1 trial for tirzepatide (Jastreboff et al., 2022, New England Journal of Medicine), weight loss was not linear across the treatment period. Rate of loss naturally slows as you approach a new equilibrium.
  • Do not self-adjust your dose based on a plateau. That conversation belongs with your prescriber, who can assess whether titration, adherence, or other clinical factors are relevant.
  • Sleep, resistance training, and protein intake all influence whether weight loss comes from fat versus lean mass during a deficit. These are not discussed in the video but are relevant to how plateau management plays out over time.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

✨️Heather✨️ First Time Mum 🤍 · TikTok creator

2.0K views on this video

the plateau WILL END 👏 #weightlossjourney #plateau #glp1forweightloss #glp1 #mounjarocommunity #mounjarouk #mounjarojourney

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about tdee decreases by roughly 300 to 500 calories after a?

TDEE decreases by roughly 300 to 500 calories after a 38 kg weight loss, making stale calorie targets a genuine and common plateau driver supported by Hall et al. (2022, Obesity).

What does the video say about adaptive thermogenesis means your actual metabolic rate can sit below?

Adaptive thermogenesis means your actual metabolic rate can sit below what TDEE calculators predict after major weight loss, documented in Rosenbaum and Leibel (2010, NEJM).

What does the video say about surmount-1 trial data (jastreboff et al., 2022, nejm) shows tirzepatide-associated?

SURMOUNT-1 trial data (Jastreboff et al., 2022, NEJM) shows tirzepatide-associated weight loss is not linear, and plateau periods are expected within the normal treatment course.

What does the video say about recalculating tdee using current bodyweight via the mifflin-st jeor equation?

Recalculating TDEE using current bodyweight via the Mifflin-St Jeor equation is a reasonable first step when plateaued, but it is an estimate, not a personalised metabolic measurement.

Dose adjustments for GLP-1 medications should never be self-directed based on a plateau. This is a clinical decision requiring prescriber input?

Dose adjustments for GLP-1 medications should never be self-directed based on a plateau. This is a clinical decision requiring prescriber input.

What does the video say about a plateau lasting more than six to eight weeks on?

A plateau lasting more than six to eight weeks on a GLP-1 medication warrants a conversation with your prescriber, not just a calorie audit.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by ✨️Heather✨️ First Time Mum 🤍, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.